Video Experimental Relacionado
Updated: Feb 9, 2026
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
20.1K
Desafíos actuales de la hipersensibilidad a medicamentos en pacientes con fibrosis quística
Joshua Gardner1, Elsie Clarke1, Daniel Peckham2
1Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.
Resumen
Los moduladores del regulador de la conductancia transmembrana de la fibrosis quística (CFTR) mejoran la función de la proteína CFTR. Si bien son generalmente seguros, algunos pacientes experimentan alergias a medicamentos, que pueden estar relacionadas con la inflamación y problemas de las células T, lo que afecta los resultados del tratamiento.
Área de la Ciencia:
- Farmacología
- Inmunología
- Neumología
Sus antecedentes:
- Los pacientes con Fibrosis Quística (FQ) a menudo enfrentan hipersensibilidad a medicamentos, particularmente a antibióticos beta-lactámicos como la piperacilina.
- Se postulan reacciones mediadas por células T en reacciones adversas no inmediatas dentro de la población de FQ.
- La inflamación exagerada y la desregulación inmunitaria pueden contribuir a la prevalencia de reacciones a medicamentos en la FQ.
Objetivo del estudio:
- Revisar la seguridad de los medicamentos en pacientes con CF que utilizan la terapia con moduladores de CFTR.
- Explorar la incidencia y las características de las reacciones adversas a los medicamentos de los moduladores de CFTR.
- Investigar la relación entre la hipersensibilidad a medicamentos preexistente y la tolerancia a los moduladores de CFTR.
Principales métodos:
- Revisión de la literatura sobre reacciones adversas a medicamentos en pacientes con FQ en tratamiento con moduladores de CFTR.
- Análisis de los mecanismos de hipersensibilidad mediada por células T en la FQ.
- Examen de datos de pacientes sobre la tolerancia a los moduladores de CFTR después de eventos de hipersensibilidad a medicamentos.
Principales resultados:
- Las reacciones adversas graves a los moduladores de CFTR son infrecuentes pero pueden provocar la interrupción del tratamiento.
- Algunos pacientes con CF desarrollan alergias relacionadas con medicamentos, incluso con estados inmunitarios mejorados por los moduladores de CFTR.
- En particular, los pacientes con hipersensibilidad previa a medicamentos toleran los moduladores de CFTR sin desensibilización.
Conclusiones:
- Las reacciones adversas a los moduladores de CFTR, aunque raras, son clínicamente significativas y requieren comprensión.
- La hipersensibilidad a los moduladores de CFTR puede estar influenciada por la inflamación y la función de las células T reguladoras en la FQ.
- La tolerancia observada a los moduladores de CFTR en pacientes previamente hipersensibles sugiere interacciones inmunitarias complejas en la FQ.
Palabras clave:
moduladores de CftrFibrosis quísticaHipersensibilidad a medicamentosInflamaciónLinfocitos TMás Videos Relacionados
07:25Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
3.6K
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
583
Videos de Conceptos Relacionados
01:23Cystic Fibrosis: Pathogenesis
891
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
891
01:24Cystic Fibrosis: Management
546
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
546
01:30Hypersensitivities
7.7K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.7K
01:15Drug Dosing: Geriatric Patients
278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
01:21Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266